NRx pharmaceuticals files New Drug Application for ketamine depression treatment
NRx is pushing its NMDA platform while building a national network of psychiatric treatment centers.
The post NRx pharmaceuticals files New Drug Application for ketamine depression treatment appeared first on Green Market Report.
